In trials with patients with type 2 diabetes and overweight/obesity, after 16 weeks of treatment with Danuglipron, the high-dose (120 mg twice daily) group showed an average weight loss of 4.2 kg and a reduction in HbA1c levels by 1.2% compared to the placebo group
This stops the cravings for sugary, processed foods helping patients make better food choices
Calibrate members lose, on average, 18% of their body weight and learn how to keep it off
Available in Australia with fast dispatch, this dual-peptide format supports simplified workflows and consistent laboratory conditions
This open dialogue ensures that your medical professionals have the complete picture, allowing them to provide the safest and most effective recommendations tailored to your individual health profile
If the choice is between taking GLP-1 meds and losing weight or developing a dozen life-threatening conditions due to excess weight, the answer is obvious
